Keep up to date with what is going on at Deepbridge, our investee companies and other exciting news.
IbisVision Extends NHS Contract
IbisVision, which is part of the Deepbridge Life Sciences EIS portfolio, has recently extended their contract with Forth Valley NHS while their…
Full articleResearch reveals advisers prefer EIS to VCT
Deepbridge have recently concluded an adviser survey that suggests financial advisers utilise the Enterprise Investment Scheme (EIS) investment…
Full articleGenome Diagnostics closes £1.4m Funding Round
GenoME Diagnostics, an investee company within Deepbridge's Life Sciences SEIS portfolio has recently closed a £1.4 million funding round which will…
Full articleSuccessful results from Enso Tyres
ENSO Tyres Limited, one of Deepbridge's Technology Growth EIS Companies, has "successfully proven" the benefits of its specially…
Full articleAndrew Aldridge Appointed to EISA Board
The Enterprise Investment Scheme Association (EISA) has appointed Andrew Aldridge (Partner & Chief Marketing Officer at Deepbridge Capital) to…
Full articleTax year End - EIS Opportunities
As we rapidly approach tax year end and clients submit their self-assessment tax returns, financial adviser’s attention will be drawn to tax planning…
Full articleIHT Receipits Hit £5.3 Billion
HM Revenue and Customs (HMRC) recorded a £700 Million uptick in Inheritance Tax (IHT) receipts between April and December last year, totalling £5.3…
Full articleDeepbridge Appoints New Senior Investment Director
Deepbridge are pleased to announce the appointment of Dr Andy Round, as Senior Investment Director, within the Deepbridge Life Sciences EIS team.…
Full articleMedTech Trends in 2023
Bernard Ross, CEO and Founder of Sky Medical Technology Ltd. has recently been featured in a Med-Tech News article regarding what he expects from the…
Full articleMicroplate DX Secures £500k Funding
Award-winning University of Strathclye spinout company, Microplate Dx Limited has recently secured significant seed funding to scale-up development…
Full articleLiverpool Chirochem Secures £2.2m Investment
Liverpool ChiroChem Ltd. (LCC), an investee company within Deepbridge Capital's Life Science EIS fund, has recently raised £2.2 million of investment…
Full article